Cite
HARVARD Citation
Gyawali, B. et al. (2018). Negative phase 3 randomized controlled trials: Why cancer drugs fail the last barrier?. International journal of cancer. 143 (8), pp. 2079-2081. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gyawali, B. et al. (2018). Negative phase 3 randomized controlled trials: Why cancer drugs fail the last barrier?. International journal of cancer. 143 (8), pp. 2079-2081. [Online].